Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 01, 2026
TickeronGET DAILY SIGNALS
Philip Morris International (PM): Path to the $230 Analyst Target

Philip Morris International (PM): Path to the $230 Analyst Target

Key Takeaways

  • The central target used here is $230, roughly 10% above Philip Morris International's latest closing price of about $208.79.
  • This objective is drawn from public discussion — specifically the top of the current analyst price-target range — not from a calculated consensus, because the average analyst target sits too close to the market price to be meaningful.
  • The verified analyst range is wide, roughly $175 to $230, with an average near $211, reflecting genuine disagreement about valuation.
  • The strongest support is accelerating smoke-free growth in PM's ZYN nicotine pouches and IQOS heated-tobacco devices.
  • The biggest risks are a trimmed full-year earnings outlook, foreign-exchange and geopolitical headwinds, and a premium valuation.
  • Get more on the company's Major News, Today's Price Move, Forecast, and Earnings, and explore Trending AI Robots for additional market insight.

Setting the $230 Target

Philip Morris International Inc. (PM) is a consumer-staples stock, not an ETF. Because the average analyst price target of roughly $211 is barely above the latest close, it fails the standard test for a useful "can it reach" question. The $230 figure is therefore presented as a publicly discussed price objective — the high end of the current analyst range — rather than a consensus forecast.

For context, data aggregators report roughly 15 to 16 covering analysts with a "Buy" consensus and an average 12-month target near $210, within a range of about $175 to $230. Individual, dated targets include Barclays at $225, Citigroup at $225, Goldman Sachs at $222, Argus Research at $220, Needham at $220, Morgan Stanley at $215, and Bank of America at $211. More cautious views include UBS at $201 (Neutral) and Stifel at $205, while older targets from Jefferies ($180) and J.P. Morgan ($185) anchor the lower end. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

Shares last closed near $208.79, within a 52-week range of roughly $142.11 to $214.35. Reaching $230 would require an advance of about 10% — a modest move for a large-cap staple, but one that would require a decisive break above the recent record-high zone near $214 before any approach to $230 becomes realistic.

The fundamental backdrop is mixed. Philip Morris beat third-quarter estimates on strong smoke-free demand and tobacco pricing, but management trimmed its 2026 adjusted EPS guidance to a range of roughly $8.29 to $8.44, citing global conflicts and a clouded outlook. ZYN shipment growth has been exceptional, and smoke-free products now contribute about 40% of revenue, but the stock already trades at a premium P/E near 30 times trailing earnings.

What Could Support a Move Toward the Target

  • Smoke-free momentum: Rapid ZYN and IQOS growth, including new manufacturing capacity in Colorado, supports the strategic shift away from cigarettes.
  • Pricing power and cash flow: The combustible business remains highly cash-generative, funding a dividend of roughly $6.40 annually (about a 3% yield).
  • Analyst revisions higher: Argus, Barclays, Citigroup, and Bank of America raised targets through 2026, reflecting confidence in the growth narrative.
  • Defensive appeal: In uncertain markets, stable consumer-staples earnings and dividends can attract rotation into names like PM.

What Could Prevent the Target From Being Reached

  • Guidance trim: The lower end of the 2026 EPS outlook and management's caution about geopolitical disruption weigh on sentiment.
  • Valuation: A premium multiple leaves less room for error if growth decelerates or the dollar strengthens against key currencies.
  • Regulatory risk: Nicotine-pouch and heated-tobacco categories face evolving regulation across major markets.
  • Competition: Rival oral-nicotine and reduced-risk products are expanding, pressuring market share.
  • Technical resistance: The recent all-time high near $214 is the first hurdle; a failure to hold above $200 could signal fading momentum.

Technical Levels and Market Structure

PM's most durable reference points are the 52-week low near $142 and the record high near $214, the latter acting as immediate resistance. The round-number $200 level has served as both support and a psychological marker, while the $191 to $196 zone corresponds to recent longer-term moving averages. A sustained close above $214 would be the first meaningful sign that a move toward $230 is developing, whereas a breakdown below $200 would likely reset the discussion toward the lower end of the analyst range.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms do not always state a fixed timeframe. Investors should watch upcoming quarterly results and guidance updates, analyst target revisions, currency moves (given PM's substantial international revenue), regulatory decisions on nicotine products, and ZYN and IQOS shipment trends. Any acceleration — or stall — in smoke-free volume growth is likely to be the single most important driver of whether the shares can extend toward $230. From what I see, this is important because it ties directly to the company's transformation narrative.

Final Assessment

The $230 objective is the high end of the current analyst price-target range, not an average or consensus, and it implies a roughly 10% advance from the latest price near $208.79. The bull case rests on exceptional smoke-free growth and strong pricing, while the bear case centers on trimmed guidance, currency headwinds, a premium valuation, and regulatory uncertainty. The wide $175-to-$230 analyst range underscores real disagreement about how much the transformation is worth. Reaching $230 is possible, but it would require clearing the recent record high and sustaining smoke-free momentum against a demanding valuation — an outcome that is far from guaranteed.

Using AI Tools for Ongoing Monitoring

In my analysis of names like PM, I often turn to Tickeron’s AI Daily Buy/Sell Signals to track shifts in technical behavior alongside the fundamentals. The platform monitors thousands of stocks in real time, helping surface potential entry or exit points based on AI-driven signals. It has become a useful complement to traditional research when evaluating whether momentum is building toward a target like $230.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


PM sees MACD Histogram just turned negative

PM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 05, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In 28 of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PM as a result. In 39 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 50%.

PM moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PM crossed bearishly below the 50-day moving average on November 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 43%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.

PM broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where PM advanced for three days, in 239 of 392 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PM's P/B Ratio (-35.934) is slightly lower than the industry average of (-7.297). P/E Ratio (28.431) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (2.327) is also within normal values, averaging (3.595). Dividend Yield (0.032) settles around the average of (0.060) among similar stocks. PM's P/S Ratio (7.022) is slightly higher than the industry average of (2.780).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. PM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 57.21B. The market cap for tickers in the group ranges from 99 to 308.42B. PM holds the highest valuation in this group at 308.42B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -19%. For the same Industry, the average monthly price growth was -24%, and the average quarterly price growth was -35%. MO experienced the highest price growth at -5%, while XXII experienced the biggest fall at -56%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was 90%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 52
Price Growth Rating: 70
SMR Rating: 73
Profit Risk Rating: 71
Seasonality Score: 35 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of cigarettes and other tobacco products

Industry Tobacco

Industry
Tobacco
Address
677 Washington Boulevard
Phone
+1 203 905-2410
Employees
84900
Web
https://www.pmi.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.